Season Greetings A very happy holiday season from the whole AMAL team, and a great start into 2022 ! AMAL Therapeutics to publish research outcomes in CancersJoint Team Effort Succeeds in Advancing First-in-Cass Triple Combination Immunotherapy to Studies in Patients with Colorectal Cancer
